Vulvodynia

Assessment and Treatment

Andrew T. Goldstein, Caroline F. Pukall, Candace Brown, Sophie Bergeron, Amy Stein, Susan Kellogg-Spadt

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Introduction Vulvodynia constitutes a highly prevalent form of sexual pain in women, and current information regarding its assessment and treatment is needed. Aim To update the scientific evidence published in 2010, from the Third International Consultation on Sexual Medicine, pertaining to the assessment and treatment of women's sexual pain. Methods An expert committee, as part of the Fourth International Consultation on Sexual Medicine, was comprised of researchers and clinicians from biological and social science disciplines for the review of the scientific evidence on the assessment and treatment of women's genital pain. Main Outcome Measures A review of assessment and treatment strategies involved in vulvodynia. Results We recommend the following treatments for the management of vulvodynia: psychological interventions, pelvic floor physical therapy, and vestibulectomy (for provoked vestibulodynia). We also support the use of multidisciplinary treatment approaches for the management of vulvodynia; however, more studies are needed to determine which components are most important. We recommend waiting for more empirical evidence before recommending alternative treatment options, anti-inflammatory agents, hormonal agents, and anticonvulsant medications. Although we do not recommend lidocaine, topical corticosteroids, or antidepressant medication for the management of vulvodynia, we suggest that capsaicin, botulinum toxin, and interferon be considered second-line avenues and that their recommendation be revisited once further research is conducted. Conclusion A comprehensive assessment is needed to understand the pain experience of women presenting with vulvodynia. In addition, treatment typically progresses from less invasive to more invasive, and several treatment options are worth pursuing.

Original languageEnglish (US)
Pages (from-to)572-590
Number of pages19
JournalJournal of Sexual Medicine
Volume13
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Vulvodynia
Therapeutics
Pain
Referral and Consultation
Medicine
Pelvic Floor
Botulinum Toxins
Biological Science Disciplines
Social Sciences
Capsaicin
Lidocaine
Anticonvulsants
Interferons
Antidepressive Agents
Adrenal Cortex Hormones
Anti-Inflammatory Agents

All Science Journal Classification (ASJC) codes

  • Reproductive Medicine
  • Obstetrics and Gynecology
  • Urology

Cite this

Goldstein, A. T., Pukall, C. F., Brown, C., Bergeron, S., Stein, A., & Kellogg-Spadt, S. (2016). Vulvodynia: Assessment and Treatment. Journal of Sexual Medicine, 13(4), 572-590. https://doi.org/10.1016/j.jsxm.2016.01.020

Vulvodynia : Assessment and Treatment. / Goldstein, Andrew T.; Pukall, Caroline F.; Brown, Candace; Bergeron, Sophie; Stein, Amy; Kellogg-Spadt, Susan.

In: Journal of Sexual Medicine, Vol. 13, No. 4, 01.04.2016, p. 572-590.

Research output: Contribution to journalArticle

Goldstein, AT, Pukall, CF, Brown, C, Bergeron, S, Stein, A & Kellogg-Spadt, S 2016, 'Vulvodynia: Assessment and Treatment', Journal of Sexual Medicine, vol. 13, no. 4, pp. 572-590. https://doi.org/10.1016/j.jsxm.2016.01.020
Goldstein AT, Pukall CF, Brown C, Bergeron S, Stein A, Kellogg-Spadt S. Vulvodynia: Assessment and Treatment. Journal of Sexual Medicine. 2016 Apr 1;13(4):572-590. https://doi.org/10.1016/j.jsxm.2016.01.020
Goldstein, Andrew T. ; Pukall, Caroline F. ; Brown, Candace ; Bergeron, Sophie ; Stein, Amy ; Kellogg-Spadt, Susan. / Vulvodynia : Assessment and Treatment. In: Journal of Sexual Medicine. 2016 ; Vol. 13, No. 4. pp. 572-590.
@article{bbe071c1d7684efd8e4ad7667ef8340e,
title = "Vulvodynia: Assessment and Treatment",
abstract = "Introduction Vulvodynia constitutes a highly prevalent form of sexual pain in women, and current information regarding its assessment and treatment is needed. Aim To update the scientific evidence published in 2010, from the Third International Consultation on Sexual Medicine, pertaining to the assessment and treatment of women's sexual pain. Methods An expert committee, as part of the Fourth International Consultation on Sexual Medicine, was comprised of researchers and clinicians from biological and social science disciplines for the review of the scientific evidence on the assessment and treatment of women's genital pain. Main Outcome Measures A review of assessment and treatment strategies involved in vulvodynia. Results We recommend the following treatments for the management of vulvodynia: psychological interventions, pelvic floor physical therapy, and vestibulectomy (for provoked vestibulodynia). We also support the use of multidisciplinary treatment approaches for the management of vulvodynia; however, more studies are needed to determine which components are most important. We recommend waiting for more empirical evidence before recommending alternative treatment options, anti-inflammatory agents, hormonal agents, and anticonvulsant medications. Although we do not recommend lidocaine, topical corticosteroids, or antidepressant medication for the management of vulvodynia, we suggest that capsaicin, botulinum toxin, and interferon be considered second-line avenues and that their recommendation be revisited once further research is conducted. Conclusion A comprehensive assessment is needed to understand the pain experience of women presenting with vulvodynia. In addition, treatment typically progresses from less invasive to more invasive, and several treatment options are worth pursuing.",
author = "Goldstein, {Andrew T.} and Pukall, {Caroline F.} and Candace Brown and Sophie Bergeron and Amy Stein and Susan Kellogg-Spadt",
year = "2016",
month = "4",
day = "1",
doi = "10.1016/j.jsxm.2016.01.020",
language = "English (US)",
volume = "13",
pages = "572--590",
journal = "Journal of Sexual Medicine",
issn = "1743-6095",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Vulvodynia

T2 - Assessment and Treatment

AU - Goldstein, Andrew T.

AU - Pukall, Caroline F.

AU - Brown, Candace

AU - Bergeron, Sophie

AU - Stein, Amy

AU - Kellogg-Spadt, Susan

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Introduction Vulvodynia constitutes a highly prevalent form of sexual pain in women, and current information regarding its assessment and treatment is needed. Aim To update the scientific evidence published in 2010, from the Third International Consultation on Sexual Medicine, pertaining to the assessment and treatment of women's sexual pain. Methods An expert committee, as part of the Fourth International Consultation on Sexual Medicine, was comprised of researchers and clinicians from biological and social science disciplines for the review of the scientific evidence on the assessment and treatment of women's genital pain. Main Outcome Measures A review of assessment and treatment strategies involved in vulvodynia. Results We recommend the following treatments for the management of vulvodynia: psychological interventions, pelvic floor physical therapy, and vestibulectomy (for provoked vestibulodynia). We also support the use of multidisciplinary treatment approaches for the management of vulvodynia; however, more studies are needed to determine which components are most important. We recommend waiting for more empirical evidence before recommending alternative treatment options, anti-inflammatory agents, hormonal agents, and anticonvulsant medications. Although we do not recommend lidocaine, topical corticosteroids, or antidepressant medication for the management of vulvodynia, we suggest that capsaicin, botulinum toxin, and interferon be considered second-line avenues and that their recommendation be revisited once further research is conducted. Conclusion A comprehensive assessment is needed to understand the pain experience of women presenting with vulvodynia. In addition, treatment typically progresses from less invasive to more invasive, and several treatment options are worth pursuing.

AB - Introduction Vulvodynia constitutes a highly prevalent form of sexual pain in women, and current information regarding its assessment and treatment is needed. Aim To update the scientific evidence published in 2010, from the Third International Consultation on Sexual Medicine, pertaining to the assessment and treatment of women's sexual pain. Methods An expert committee, as part of the Fourth International Consultation on Sexual Medicine, was comprised of researchers and clinicians from biological and social science disciplines for the review of the scientific evidence on the assessment and treatment of women's genital pain. Main Outcome Measures A review of assessment and treatment strategies involved in vulvodynia. Results We recommend the following treatments for the management of vulvodynia: psychological interventions, pelvic floor physical therapy, and vestibulectomy (for provoked vestibulodynia). We also support the use of multidisciplinary treatment approaches for the management of vulvodynia; however, more studies are needed to determine which components are most important. We recommend waiting for more empirical evidence before recommending alternative treatment options, anti-inflammatory agents, hormonal agents, and anticonvulsant medications. Although we do not recommend lidocaine, topical corticosteroids, or antidepressant medication for the management of vulvodynia, we suggest that capsaicin, botulinum toxin, and interferon be considered second-line avenues and that their recommendation be revisited once further research is conducted. Conclusion A comprehensive assessment is needed to understand the pain experience of women presenting with vulvodynia. In addition, treatment typically progresses from less invasive to more invasive, and several treatment options are worth pursuing.

UR - http://www.scopus.com/inward/record.url?scp=84988473744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988473744&partnerID=8YFLogxK

U2 - 10.1016/j.jsxm.2016.01.020

DO - 10.1016/j.jsxm.2016.01.020

M3 - Article

VL - 13

SP - 572

EP - 590

JO - Journal of Sexual Medicine

JF - Journal of Sexual Medicine

SN - 1743-6095

IS - 4

ER -